Although Redx has only been operationalsince late-2010, it has already discovered several valuable drug candidates, the first of which is about to begin clinical trials. Although management is focusing resources on the clinical-stage projects, it will also be seeking partners to advance its other assets, thereby maximising shareholder value. Redx has announced the first such collaboration with CARB-X to progress its new class of antibiotics against hard to treat Gram-negative bacteria. Follow
03 Apr 2017
CARB-X – new strategic collaboration
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
CARB-X – new strategic collaboration
Redx Pharma Plc (REDX:LON) | 10.2 0 0.0% | Mkt Cap: 39.9m
- Published:
03 Apr 2017 -
Author:
Martin Hall -
Pages:
4
Although Redx has only been operationalsince late-2010, it has already discovered several valuable drug candidates, the first of which is about to begin clinical trials. Although management is focusing resources on the clinical-stage projects, it will also be seeking partners to advance its other assets, thereby maximising shareholder value. Redx has announced the first such collaboration with CARB-X to progress its new class of antibiotics against hard to treat Gram-negative bacteria. Follow